ADAPTIMMUNE THERAPEUTICS PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 8.98M shares, a 38.58% decline from fiscal 2023.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 14.61M shares, a 150.95% increase from fiscal 2022.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 5.82M shares, a 1.75% increase from fiscal 2021.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 5.72M shares, a 49.80% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2024-12-31 | 8.98M shares 10-K · filed 2025-03-24 | |
| 2023-12-31 | 14.61M shares 10-K · filed 2025-03-24 | |
| 2022-12-31 | 5.82M shares 10-K · filed 2025-03-24 | |
| 2021-12-31 | 5.72M shares 10-K · filed 2024-03-06 | |
| 2020-12-31 | 11.40M shares 10-K · filed 2023-03-06 | |
| 2019-12-31 | 3.55M shares 10-K · filed 2022-03-14 | |
| 2018-12-31 | 5.33M shares 10-K · filed 2021-02-25 | |
| 2017-12-31 | 1.14M shares 10-K · filed 2019-02-27 | |
| 2016-12-31 | 63.19K shares 10-K · filed 2019-02-27 | |
| 2015-06-30 | 0.00 shares 10-K · filed 2018-03-15 | |
| 2014-06-30 | 2.27M shares 10-K · filed 2017-03-13 | |
| 2013-06-30 | 0.00 shares 8-K · filed 2016-07-08 |